Lantronix to Launch New Edge AI Solutions at CES 2026

Lantronix to Launch New Edge AI Solutions at CES 2026 Lantronix welcomes customers, channel leaders and technology innovators to discover cutting-edge solutions in an exclusive suite experience at the Wynn Las Vegas GlobeNewswire December 09, 2025 IRVINE, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) — Lantronix Inc. (NASDAQ: LTRX), a global leader in compute and connectivity […]

SailPoint Announces Fiscal Third Quarter 2026 Results

SailPoint Announces Fiscal Third Quarter 2026 Results GlobeNewswire December 09, 2025 AUSTIN, Texas, Dec. 09, 2025 (GLOBE NEWSWIRE) — SailPoint, Inc. (Nasdaq: SAIL), a leader in enterprise identity security, today announced financial results for its fiscal third quarter ended October 31, 2025. The company's earnings release and presentation can be accessed on the quarterly results

Woof Gang, America’s Largest Premium Pet Grooming Brand, Expands into New States

Woof Gang, America's Largest Premium Pet Grooming Brand, Expands into New States GlobeNewswire December 09, 2025 Opens first franchised stores in Boston, MA and Fargo, ND as part of broader growth strategy to scale to more than 450 locations in North America by 2027 MIAMI, Dec. 09, 2025 (GLOBE NEWSWIRE) — Woof Gang Bakery &

Americold Realty Trust, Inc. Announces Participation at Investor Conference

Americold Realty Trust, Inc. Announces Participation at Investor Conference Reaffirms Full-Year 2025 Financial Outlook GlobeNewswire December 09, 2025 ATLANTA, Dec. 09, 2025 (GLOBE NEWSWIRE) — Americold Realty Trust (NYSE: COLD), a global leader in temperature-controlled logistics, real estate, and value-added services focused on the ownership, operation, acquisition and development of temperature-controlled warehouses, today announced its

Aeluma Files New Patent That Enhances Intellectual Property for Large-Scale High Performance Semiconductor Manufacturing

Aeluma Files New Patent That Enhances Intellectual Property for Large-Scale High Performance Semiconductor Manufacturing Strengthens Aeluma's Heterogeneous Integration Platform and Expands Intellectual Property Portfolio to 35 Issued and Pending Patents GlobeNewswire December 09, 2025 GOLETA, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) — Aeluma, Inc. (NASDAQ: ALMU), a semiconductor company specializing in high-performance, scalable technologies for

TopBuild Hosting 2025 Investor Day on December 9, Providing Strategic Outlook on Business

TopBuild Hosting 2025 Investor Day on December 9, Providing Strategic Outlook on Business GlobeNewswire December 09, 2025 DAYTONA BEACH, Fla., Dec. 09, 2025 (GLOBE NEWSWIRE) — TopBuild Corp., (NYSE:BLD) a leading installer of insulation and commercial roofing and a specialty distributor of insulation and related building products to the construction industry in the United States

Expert Melanoma Panel Recommends Castle Biosciences’ DecisionDx(R)-Melanoma as a Best-Practice Tool for Managing Patients with Melanoma

Expert Melanoma Panel Recommends Castle Biosciences' DecisionDx(R)-Melanoma as a Best-Practice Tool for Managing Patients with Melanoma Expert panel offers data-driven guidance for integrating DecisionDx-Melanoma into clinical decision-making for patients with melanoma GlobeNewswire December 09, 2025 FRIENDSWOOD, Texas, Dec. 09, 2025 (GLOBE NEWSWIRE) — Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests

ONL Therapeutics Announces Publication of Data from Phase 1b Study of Xelafaslatide, an Investigational Therapy for Geographic Atrophy, in Ophthalmology Science

ONL Therapeutics Announces Publication of Data from Phase 1b Study of Xelafaslatide, an Investigational Therapy for Geographic Atrophy, in Ophthalmology Science Xelafaslatide was safe and well tolerated at all evaluated doses, with the potential to reduce GA lesion growth and improve vision GlobeNewswire December 09, 2025 ANN ARBOR, Mich., Dec. 09, 2025 (GLOBE NEWSWIRE) —

Gencor Releases Fourth Quarter and Fiscal Year 2025 Results

Gencor Releases Fourth Quarter and Fiscal Year 2025 Results GlobeNewswire December 09, 2025 ORLANDO, Fla., Dec. 09, 2025 (GLOBE NEWSWIRE) — Gencor Industries, Inc. (the “Company” or “Gencor”) (NYSE American: GENC) announced today net revenue for the fourth quarter ended September 30, 2025 of $18.8 million, down 10.0% from $20.9 million net revenue for the

Psyence BioMed CEO Letter Highlights Clinical Progress, Ethical Sourcing of Ibogaine, Strong Cash Position and Expanding Leadership in Longevity Science

Psyence BioMed CEO Letter Highlights Clinical Progress, Ethical Sourcing of Ibogaine, Strong Cash Position and Expanding Leadership in Longevity Science GlobeNewswire December 09, 2025 NEW YORK, Dec. 09, 2025 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health

Scroll to Top